Published in J Exp Med on May 01, 1969
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med (1980) 2.76
The transcriptome of equine peripheral blood mononuclear cells. PLoS One (2015) 1.65
Studies of peripheral blood T-and B-lymphocytes in acute infections. Infect Immun (1974) 1.58
Reactive lymphoid cells ('Immunoblasts') in autoimmune and haematological disorders. Clin Exp Immunol (1975) 1.52
Blast transformation in vivo and in vitro in carbamazepin hypersensitivity. Clin Exp Immunol (1971) 1.51
Lymphocyte subpopulations in sarcoidosis. Clin Exp Immunol (1974) 1.43
Significance of the changes in the circulating lymphoid cells in Hodgkin's disease. Br Med J (1969) 1.35
Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease. J Clin Invest (1983) 1.22
Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins. Ann Rheum Dis (1976) 1.12
The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer (1972) 1.08
Lymphoblast proliferation and humoral antibody response after rubella vaccination. Clin Exp Immunol (1973) 1.03
Spontaneous antibody-secreting human blood lymphocytes detected with a protein A plaque assay. Clin Exp Immunol (1980) 0.96
Circulating immunoblasts in polymyalgia rheumatica. Ann Rheum Dis (1976) 0.94
Immunological function in dystrophia myotonica. Br Med J (1973) 0.92
The significance of changes in blood lymphocyte populations following surgical operations. Clin Exp Immunol (1984) 0.90
Immunoblasts in synovial fluid and blood in the rheumatic diseases. Ann Rheum Dis (1980) 0.87
Poly IC therapy in aleutian disease of mink. Can J Comp Med (1975) 0.83
Increased proliferation of T lymphocytes in the blood of patients with Hodgkin's disease. Clin Exp Immunol (1975) 0.81
New approaches to the management of patients with non-Hodgkin's lymphoma of high-grade pathology. First Gordon Hamilton-Fairley memorial lecture. Br J Cancer (1981) 0.79
LPS-induced modules of co-expressed genes in equine peripheral blood mononuclear cells. BMC Genomics (2017) 0.75
Immunologic parameters of children with urinary tract infection: effects of trimethoprim-sulfamethoxazole. Can Med Assoc J (1975) 0.75
Lack of proliferation of circulating white blood cells in patients with syphilis before and after a Jarisch-Herxheimer reaction. Br J Vener Dis (1978) 0.75
Atypical mononuclear cells in the blood. Br Med J (1971) 0.75
The nucleic acid content of lymphocytes in thyrotoxicosis. Clin Exp Immunol (1971) 0.75
THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT. Proc R Soc Lond B Biol Sci (1964) 20.20
Autoradiographic studies on the immune response.I. The kinetics of plasma cell proliferation. J Exp Med (1962) 9.43
Studies on antibody production. II. The primary and secondary responses in the popliteal lymph node of the rabbit. J Exp Med (1955) 6.56
THE FORMATION OF AGGLUTININS WITHIN LYMPH NODES. J Exp Med (1935) 6.30
The output of cells in lymph from the popliteal node of sheep. Q J Exp Physiol Cogn Med Sci (1962) 4.73
The lymph-borne cells of the immune response. Q J Exp Physiol Cogn Med Sci (1963) 4.64
Response of human blood lymphocytes to tuberculin PPD in tissue culture. Immunology (1967) 4.09
Autoradiographic studies on the immune response. II. DNA synthesis amongst single antibody-producing cells. J Exp Med (1962) 3.71
Electron microscopic observations on antibody-producing lymph node cells. J Exp Med (1966) 3.25
The ultrastructure and function of the cells in lymph following antigenic stimulation. J Exp Med (1967) 2.98
The atypical lymphocyte. Am J Med (1967) 2.83
THE ROLES OF CELLULAR DIVISION AND MATURATION IN THE FORMATION OF PRECIPITATING ANTIBODY. J Immunol (1963) 2.78
Studies of the cells in the afferent and efferent lymph of lymph nodes draining the site of skin homografts. J Exp Med (1967) 2.31
Electron microscopic observations on antibody-producing cells in lymph and blood. J Exp Med (1966) 1.86
ONSET AND DURATION OF DNA SYNTHESIS IN ANTIBODY FORMING CELLS AFTER ANTIGEN. J Exp Med (1965) 1.79
Synthesis of antibodies by blood leucocytes of the rabbit. Nature (1963) 1.77
Deoxyribonucleic acid synthesizing cells in peripheral blood of normal human beings. Science (1958) 1.77
Transformation, in vivo, of basophilic lymph cells into plasma cells. Nature (1967) 1.49
The relationship of infection and DNA-synthesizing cells in human blood. J Lab Clin Med (1967) 1.30
Lymphoid cells in Hodgkin's disease. Nature (1967) 1.23
Incorporation of thymidine labelled with tritium by circulating cells of infectious mononucleosis. Nature (1959) 1.06
Electron-microscopy of Türk cells. Br J Haematol (1967) 0.89
Desoxyribonucleic acid synthesis in the lymphocytes of patients with malignant disease. Eur J Cancer (1967) 0.83
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group. J Clin Oncol (1998) 3.64
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Management of adult acute myelogenous leukaemia. Br Med J (1973) 3.33
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res (1994) 3.20
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol (1994) 2.94
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Immunity to malignant disease in man. Br Med J (1969) 2.88
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J (1971) 2.82
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Br Med J (1970) 2.51
Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J (1971) 2.50
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97
Six cases of gamma-D myelomatosis. Lancet (1966) 1.92
The recognition of psychiatric morbidity on a medical oncology ward. J Psychosom Res (1989) 1.84
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol (1988) 1.73
Combination chemotherapy in generalized Hodgkin's disease. Br Med J (1970) 1.67
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65
Psychological problems associated with diagnosis and treatment of lymphomas. I: Retrospective study. Br Med J (Clin Res Ed) (1987) 1.60
p53 germline mutations in Li-Fraumeni syndrome. Lancet (1991) 1.58
Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood (1993) 1.56
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Reactive lymphoid cells ('Immunoblasts') in autoimmune and haematological disorders. Clin Exp Immunol (1975) 1.52
MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J (1978) 1.46
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2. Physiol Genomics (2001) 1.46
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood (1992) 1.45
A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma. Cancer Chemother Pharmacol (1986) 1.43
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer (1977) 1.43
Relative activities of linear and cyclic electron flows during chloroplast CO2-fixation. Biochim Biophys Acta (1980) 1.42
L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J (1970) 1.39
A phase I study of intravenous bryostatin 1 in patients with advanced cancer. Br J Cancer (1993) 1.38
The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancer. Br J Obstet Gynaecol (1989) 1.38
Significance of the changes in the circulating lymphoid cells in Hodgkin's disease. Br Med J (1969) 1.35
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
Computed tomography of abdomen in staging and clinical management of lymphoma. Br Med J (1978) 1.34
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
Factors influencing prognosis in adults with acute myelogenous leukaemia. Br J Cancer (1975) 1.29
The involvement of ferredoxin-NADP+ reductase in cyclic electron transport in chloroplasts. Biochim Biophys Acta (1981) 1.29
Acute leukemia in adults. Semin Hematol (1974) 1.28
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer (1998) 1.27
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer (1982) 1.26
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Br Med J (1978) 1.25
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
Lymphoid cells in Hodgkin's disease. Nature (1967) 1.23
Cellular resistance to tumours. Br Med Bull (1967) 1.22
Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records. BMJ (1997) 1.20
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion. Br J Cancer (1995) 1.19
Active immunotherapy in treatment of acute leukaemia. Br Med J (1969) 1.19
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma. Br J Cancer (1977) 1.18
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18
Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations. Clin Exp Immunol (1981) 1.16
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma. J Clin Oncol (1998) 1.15
Partial characterization of cyclic electron transport in intact chloroplasts. Arch Biochem Biophys (1980) 1.15
Abdomino-pelvic computed tomography in the management of ovarian carcinoma. Radiology (1983) 1.15
A method for following human lymphocyte traffic using indium-111 oxine labelling. Clin Exp Immunol (1981) 1.15
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer (1988) 1.14
Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood. Br J Cancer (1980) 1.11
Computed tomography (CT) in the staging of patients with Hodgkin's Disease: a report on 136 patients. Clin Radiol (1980) 1.10
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood (1993) 1.08
Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur J Cancer (1991) 1.08
Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol (1987) 1.07
Combination chemotherapy for acute lymphoblastic leukaemia in adults. Br Med J (1978) 1.06
A study of gastro-intestinal lymphoma. Clin Oncol (1979) 1.05
Early central nervous system involvement in adults with acute non-myelogenous leukaemia. Br J Cancer (1977) 1.05
Intensive investigation in management of Hodgkin's disease. Br Med J (1976) 1.04
Electron transport pathways in spinach chloroplasts. Reduction of the primary acceptor of photosystem II by reduced nicotinamide adenine dinucleotide phosphate in the dark. Biochim Biophys Acta (1979) 1.03
Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres. Br J Cancer (1988) 1.02
L-asparaginase and human malignant disease. Nature (1971) 1.01
Factors influencing microculture in leukaemia cells. Nature (1974) 1.01
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro. Cancer Immunol Immunother (1994) 1.00
Evidence for antigenicity in human tumours with reference to both melanoma and acute leukaemia. Br Med J (1970) 1.00
Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp Cell Biol (1987) 1.00
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer (1983) 1.00
Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study. Br Med J (Clin Res Ed) (1987) 0.99
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol (1995) 0.98
Adriamycin in the treatment of acute leukaemia. Br Med J (1972) 0.98
Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. Br J Cancer (1994) 0.98
The Cotswolds report on the investigation and staging of Hodgkin's disease. Br J Cancer (1990) 0.97
VAD chemotherapy--toxicity and efficacy--in patients with multiple myeloma and other lymphoid malignancies. Hematol Oncol (1987) 0.97
Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. Br J Cancer (1994) 0.97
Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. Br J Cancer (1989) 0.96
Cytochrome function in the cyclic electron transport pathway of chloroplasts. Biochim Biophys Acta (1979) 0.95